Yo, AeonicSlumber (or anyone else in the biz who might know)

PureXul

Member
Jul 31, 2006
633
7
18
Any idea why Spinefarm has been slacking on US releases for the past year or so? Moonsorrow's last album took a while to get a domestic release (not sure there even has been a domestic CD release, I know an mp3 one finally came out), Swallow the Sun's new album has no domestic release date that I've been able to find...there are probably other examples, but these are two bands who have been on an upswing in the US, especially Moonsorrow. Did Spinefarm lose a US publishing/distribution deal or something? Or are they just electing to let people buy imports because they don't think it's worthwhile to release it over here?
 
Well there's a short and a long answer and I can give you both.

The short of it is that Spinefarm has been weak US. From about 2007-2009 they had a decent US situation with Fontina/Universal doing their distro, but I am guessing Ensiferum, Swallow the Sun, etc flopped (I think the last Ensiferum did a little bit over 1,000 first week, which is terrible for a band that spent so much time in the US. I mean, they did Paganfest, direct support for Amon Amarth, a tour with Hypocrisy (although Hypocrisy bailed), and Summer Slaughter -- I think expectations were much higher. STS also did a pretty large sum of touring between those years as well over here and I don't even think the last record even had a chart debut. It's a shame really, because Spinefarm is a great label with talented people at the helm running it, but for some reason, they never were able to get success here. Even Bodom was licensed to Metal Blade for the last one, and according to rumors, even THAT release was a disappointment from a sales standpoint. Nightwish has always been licensed to Roadrunner for over here. So at this point, I can understand why this country is not a priority market for the label considering that they are extremely successful in Europe and the UK.

The long of it is that retail distributors have different release schedules and really set the times for release. Spinefarm and Swallow the Sun may want to put the record out around the time of the European release, but whoever is distributing the label now may not be able to due to its schedule, and being able to meet those two schedules at the same time is an impossible dance (especially considering that there are also publicists that need about 3 months to push the record). That's why even Nightwish for example had to get released during different periods throughout the past 2-3 months. December is typically a no-no for releases in the US, because the CD buying population decides to mainly spend its money on Christmas albums or best-of compilations since those make great gifts. Michael Buble is one such example of how successful Christmas albums can be during this period, and trying to compete with that is suicide. So naturally, Roadrunner would release the Nightwish record over here in January and not December (which is when Spinefarm and Nuclear Blast put out Nightwish). There are also other reasons too -- sometimes a band may be signed to multiple labels for different territories. Sometimes one label might have it in the contract that they get to release the record first. This is a pretty common thing in Japan, in which the label can demand to get the record released 2 weeks before everyone else at a minimum. So yeah, often times trying to sync retail schedules together is simply an impossible feat.
 
Well there's a short and a long answer and I can give you both.

The short of it is that Spinefarm has been weak US. From about 2007-2009 they had a decent US situation with Fontina/Universal doing their distro, but I am guessing Ensiferum, Swallow the Sun, etc flopped (I think the last Ensiferum did a little bit over 1,000 first week, which is terrible for a band that spent so much time in the US. I mean, they did Paganfest, direct support for Amon Amarth, a tour with Hypocrisy (although Hypocrisy bailed), and Summer Slaughter -- I think expectations were much higher. STS also did a pretty large sum of touring between those years as well over here and I don't even think the last record even had a chart debut.
Wow, just went back and looked (quick Blabbermouth search) - Ensiferum sold ~900 copies first week of "From Afar" and StS did ~400 with "New Moon". Fucking ouch, that would explain why Spinefarm is gun-shy about the US market. These bands seem to do well over here touring (Ensiferum and Moonsorrow moreso than StS), but I guess they just don't move units.

Even Bodom was licensed to Metal Blade for the last one, and according to rumors, even THAT release was a disappointment from a sales standpoint.
Wow...my personal views on Bodom's decline in quality aside, it seems like the gap between drawing on tour and moving units is getting even worse.

Thanks for the info though, I've heard the general info about different release dates for different territories over the years, but I didn't realize how badly some of Spinefarm's acts did as far as US sales. Guess I better get used to ordering imports again...
 
extremely interesting...... what's the new consensus now, if any, on how to successfully move units (physical or digital)? If this is the wide-growing trend. Pay-for-play on YouTube?
 
That's unfortunate, because the Ensiferum and StS albums are awesome.

Meanwhile, Five Finger Death Punch is huge, so is Lamb of God, and Avenged Sevenfold is still around.